MEDS Old Valuation
| MEDSDelisted Stock | USD 7.46 0.56 8.12% |
At this time, the firm appears to be overvalued. MEDS Old secures a last-minute Real Value of $7.09 per share. The latest price of the firm is $7.46. Our model forecasts the value of MEDS Old from examining the firm fundamentals such as return on equity of -2.69, and Profit Margin of 0.57 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that MEDS Old's price fluctuation is very steady at this time. Calculation of the real value of MEDS Old is based on 3 months time horizon. Increasing MEDS Old's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MEDS stock is determined by what a typical buyer is willing to pay for full or partial control of MEDS Old. Since MEDS Old is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MEDS Stock. However, MEDS Old's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.46 | Real 7.09 | Hype 7.46 | Naive 9.99 |
The intrinsic value of MEDS Old's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MEDS Old's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MEDS Old helps investors to forecast how MEDS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MEDS Old more accurately as focusing exclusively on MEDS Old's fundamentals will not take into account other important factors: MEDS Old Total Value Analysis
MEDS Old is now forecasted to have valuation of 5.69 M with market capitalization of 13.28 M, debt of 7.1 M, and cash on hands of 962.23 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the MEDS Old fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.69 M | 13.28 M | 7.1 M | 962.23 K |
MEDS Old Investor Information
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.12. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDS Old recorded a loss per share of 24.38. The entity last dividend was issued on the 19th of July 2024. The firm had 1:15 split on the 22nd of June 2023. Based on the measurements of operating efficiency obtained from MEDS Old's historical financial statements, MEDS Old is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.MEDS Old Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MEDS Old has an asset utilization ratio of 66.0 percent. This implies that the Company is making $0.66 for each dollar of assets. An increasing asset utilization means that MEDS Old is more efficient with each dollar of assets it utilizes for everyday operations.MEDS Old Ownership Allocation
The market capitalization of MEDS Old is $13.28 Million. MEDS Old secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.69 % of MEDS Old outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.MEDS Old Profitability Analysis
The company reported the previous year's revenue of 8.27 M. Net Loss for the year was (13.72 M) with profit before overhead, payroll, taxes, and interest of 4.58 M.MEDS Old Past Distributions to stockholders
About MEDS Old Valuation
The delisted stock valuation mechanism determines MEDS Old's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of MEDS Old based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of MEDS Old. We calculate exposure to MEDS Old's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MEDS Old's related companies.TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
A single share of MEDS Old represents a small ownership stake in the entity. As a stockholder of MEDS, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
MEDS Old Dividends Analysis For Valuation
Please note that MEDS Old has scaled down on payment of dividends at this time.
There are various types of dividends MEDS Old can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of MEDS shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from MEDS Old directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When MEDS pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of MEDS Old by the value of the dividends paid out.
MEDS Old Growth Indicators
Investing in growth stocks can be very risky. If the company such as MEDS Old does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.4 M | |
| Quarterly Earnings Growth Y O Y | 2.766 | |
| Forward Price Earnings | 21.8341 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in MEDS Stock
If you are still planning to invest in MEDS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEDS Old's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |